Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

McKinnon discusses ‘white space’ in R&D, about integrating generative and agentic AI with human-in-the-loop oversight while prioritising patient safety and regulatory, and how all this advances health ...

An international group of cancer experts has called for fundamental change to healthcare approaches for bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

The advancement of QEL-005 into clinical testing comes shortly after London-headquartered Quell said it was calling a temporary halt to the development of former lead programme QEL-001, designed to ...

The approval gives Ascendis a window of opportunity to eat into BioMarin's market share, as the latter works on its own ...

The Centers for Medicare & Medicaid Services (CMS) in the US has extended the deadline for companies to take part in its ...

Moderna collaborated closely with its global content partner, Wildtype (an Omnicom Health agency), to validate how AI agents fit into real-world workflows. Agencies can serve as a vital testing ground ...

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...

While Global Strategy sets the initial direction, true agility is sustained through a 360-degree loop that prioritises real-time Evidence and Strategy adjustments based on active field signals. To ...